PlainRecalls
LowClass IIITerminated

FDA Drug recall · Reported November 8, 2023

Opium Tincture, USP (Deodorized), 10 mg/mL of anhydrous morphine, packaged in 118 mL (4 Fl oz) bottles, Rx only, Manufactured for: Edenbridge Pharmaceuticals, LLC Parsippany, NJ 07054, NDC 42799-217-01

Subpotent Drug

Recall #
D-0080-2024
Affected scope
4548 bottles
Initiated
October 20, 2023
Compiled from official public sources by the editorial team.
Verify with FDA Drug →
View my saved recalls

Edenbridge Pharmaceuticals, LLC recalled Opium Tincture, USP (Deodorized), 10 mg/mL of anhydrous morphine, packaged in 118 mL (4 F… - a low-severity action.

Opium Tincture, USP (Deodorized), 10 mg/mL of anhydrous morphine, packaged in 118 mL (4 F… was recalled by Edenbridge Pharmaceuticals, LLC in November 8, 2023. Reason: Subpotent Drug. Check the official notice for the remedy. Verify recall #D-0080-2024 with the FDA Drug before acting.

The recall

Edenbridge Pharmaceuticals, LLC issued this low-severity FDA Drug recall-Subpotent Drug.

Low
severity level
Class III
classification
November 8, 2023
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0080-2024 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Drug action (record #D-0080-2024) was formally reported on November 8, 2023, with the manufacturer initiating the action on October 20, 2023. It is classified under Low severity (Class III), with a current status of Terminated. Edenbridge Pharmaceuticals, LLC is listed as the recalling firm, operating out of Parsippany, NJ. Federal records list the affected scope as 4548 bottles.

The documented reason for this recall is: Subpotent Drug Distribution data in the federal record shows the product reached: Nationwide within the United States. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Drugs & Medications recalls over time

Where this recall sits in its category - 14,287 drugs & medications recalls on record

-50005001,0001,5002,000 2006201220152018202120242026 263
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Low

Affected scope

4548 bottles

Related Recalls

6

5 from same agency

Product description

Opium Tincture, USP (Deodorized), 10 mg/mL of anhydrous morphine, packaged in 118 mL (4 Fl oz) bottles, Rx only, Manufactured for: Edenbridge Pharmaceuticals, LLC Parsippany, NJ 07054, NDC 42799-217-01

Reason for recall

Subpotent Drug

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Low (Class III)
Status Terminated
Recall number D-0080-2024
Date reported November 8, 2023
Date initiated October 20, 2023
Recalling firm Edenbridge Pharmaceuticals, LLC
Firm location Parsippany, NJ
Affected scope 4548 bottles
Distribution Nationwide within the United States

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-0080-2024) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Opium Tincture, USP (Deodorized), 10 mg/mL of anhydrous morphine, packaged in 118 mL (4 Fl oz) bottles, Rx only, Manufactured for: Edenbridge Pharmaceuticals, LLC Parsippany, NJ 07054, NDC 42799-217-01. Recalled by Edenbridge Pharmaceuticals, LLC. Units affected: 4548 bottles.
Why was this product recalled?
Subpotent Drug
Which agency issued this recall?
This recall was issued by the FDA Drug on November 8, 2023. Severity: Low. Recall number: D-0080-2024.
Where was the recalled product distributed?
Distribution: Nationwide within the United States.
How do I check if my product is affected by a recall?
Check the product description and recall number (D-0080-2024) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →

Browse all Drugs & Medications recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported November 8, 2023. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.